Avient Past Earnings Performance
Past criteria checks 0/6
Avient's earnings have been declining at an average annual rate of -8.7%, while the Chemicals industry saw earnings growing at 3.7% annually. Revenues have been declining at an average rate of 0.07% per year. Avient's return on equity is 3.5%, and it has net margins of 2.5%.
Key information
-8.68%
Earnings growth rate
-8.71%
EPS growth rate
| Chemicals Industry Growth | 12.93% |
| Revenue growth rate | -0.073% |
| Return on equity | 3.50% |
| Net Margin | 2.51% |
| Next Earnings Update | 07 May 2026 |
Recent past performance updates
Recent updates
AVNT: Future Crude Linked Cost Controls Will Support ReRating Potential
Analysts have maintained Avient’s fair value estimate at $48.57 while refining assumptions, including a slightly lower discount rate. This reflects recent price target increases from several firms, alongside a more cautious sector stance from others.AVNT: Future Crude Linked Cost Management Will Drive ReRating Potential
Analysts have modestly adjusted their price target on Avient to $48.57, with updated assumptions reflecting a slightly lower discount rate and broadly unchanged expectations for revenue growth, profit margins, and future P/E. Recent Street research cites higher crude linked input costs and mixed sector views, alongside higher individual firm targets up to $52.AVNT: Future Commodity Cost Management Will Drive ReRating Potential
Narrative Update The updated analyst price target for Avient edges lower by about $1, reflecting slightly higher discount rate assumptions and cautious views on raw material cost pressures. This comes even as several firms have recently lifted their individual targets following earnings and valuation roll-forwards.AVNT: Future End Market Recovery And Higher P/E Are Expected To ReRate Shares
Narrative Update on Avient Our analyst price target for Avient edges up from $48.25 to $49.50 as analysts cite updated valuation work, including higher forward price targets and refined expectations for revenue growth, profit margins and future P/E multiples following recent sector and company specific research. Analyst Commentary Recent research on Avient shows a mix of optimism about the longer term setup and caution around near term input cost and industry headwinds.AVNT: Demand Recovery In Key End Markets Will Drive Future Multiple
The analyst fair value estimate for Avient has moved from $41.75 to $48.25, reflecting higher Street price targets as analysts update their models and adjust assumptions around future revenue growth, profit margins, and P/E multiples. Analyst Commentary Street research on Avient over the past few months has centered on revised valuation frameworks, longer dated earnings assumptions, and how quickly demand in key end markets might stabilize.There May Be Reason For Hope In Avient's (NYSE:AVNT) Disappointing Earnings
Feb 19
Avient: Becoming A Better Business
Feb 18
Defense And Healthcare Materials Will Drive A Stronger Long Term Outlook
Catalysts About Avient Avient supplies specialized materials and color and additive solutions for end markets such as health care, defense, telecommunications, packaging and transportation. What are the underlying business or industry changes driving this perspective?AVNT: Fair View Suggests Demand Recovery And Margins Will Drive Future Multiple
Narrative Update on Avient The analyst price target for Avient has been updated to US$41.75, a US$4.75 increase from the prior US$37 level. This change reflects a combination of higher targets from some firms and lower targets from others, as well as modest adjustments to assumptions for discount rate, revenue growth, profit margin and future P/E.AVNT: Fair View Suggests Execution Will Shape Future Multiple Potential
Narrative Update on Avient The analyst price target for Avient has been adjusted slightly higher from $41.00 to $41.75, reflecting analysts’ updated views on earnings quality and valuation following recent target changes across the Street. Analyst Commentary Recent research updates on Avient present a mixed picture, with some analysts lifting targets and others trimming them, reflecting different views on how the company might execute in a challenging industry setup.AVNT: Reset Price View Will Support Future Multiple Expansion
Narrative Update Overview Analysts have trimmed their price target on Avient to US$36 from US$42, reflecting updated views on the shares while maintaining broadly consistent assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary on Avient centers on the reset in the price target to US$36.AVNT: Dividend And Buyback Execution Will Support Future Multiple Expansion
Avient's analyst price target has been reduced by $6 to $36, as analysts factor in more conservative expectations for the shares while maintaining a positive long term outlook. Analyst Commentary Analysts are recalibrating their expectations for Avient, balancing a still constructive long term view on execution and earnings power with a more tempered near term valuation framework.AVNT: New Leadership Will Drive 4% Organic Expansion As Cyclical Headwinds Ease
Avient's updated analyst price target has edged lower, reflecting a recalibration toward the mid 30 dollar to high 40 dollar range as analysts balance near term macro and cyclical pressures against improving margin prospects and the potential for faster organic growth under the new strategic focus. Analyst Commentary Recent Street research reflects a balanced mix of optimism around Avient's strategic pivot and caution on near term earnings power, resulting in a wide but grounded valuation range.AVNT: Renewed Leadership Will Drive Recovery With 4% Organic Expansion Ahead
Analysts have trimmed their price target for Avient by $1.13 to $41.00. This reflects cautious sentiment following reduced profit margin forecasts and recent reassessments of growth potential.AVNT: Renewed Leadership Will Drive Recovery In High-Growth End Markets
Analysts have modestly reduced their fair value estimate for Avient from $43.25 to $42.13. They cite a more conservative revenue growth outlook, even though profit margins and long-term growth opportunities continue to be supported by recent positive coverage and management strategy shifts.Avient (NYSE:AVNT) Will Pay A Larger Dividend Than Last Year At $0.275
Nov 05Avient (NYSE:AVNT) Is Increasing Its Dividend To $0.275
Oct 12High-Performance Healthcare Materials And Sustainable Polymers Will Create Value
Analysts have raised Avient’s price target to $43.25, citing increased confidence in the new CEO’s strategic focus on high-growth markets, anticipated organic growth, and recovery potential in cyclical end markets. Analyst Commentary Increased optimism due to the new CEO's strategic focus on high-growth platforms and markets.Avient Corporation's (NYSE:AVNT) Earnings Haven't Escaped The Attention Of Investors
Sep 13Are Investors Undervaluing Avient Corporation (NYSE:AVNT) By 30%?
Jul 14Is Avient Corporation (NYSE:AVNT) Potentially Undervalued?
May 23Is Avient (NYSE:AVNT) A Risky Investment?
May 08Is There An Opportunity With Avient Corporation's (NYSE:AVNT) 49% Undervaluation?
Apr 07Some Confidence Is Lacking In Avient Corporation's (NYSE:AVNT) P/E
Mar 23Avient: Specialty Play Slowly Becomes More Special
Mar 22At US$44.21, Is Avient Corporation (NYSE:AVNT) Worth Looking At Closely?
Feb 19Does Avient (NYSE:AVNT) Have A Healthy Balance Sheet?
Jan 20An Intrinsic Calculation For Avient Corporation (NYSE:AVNT) Suggests It's 31% Undervalued
Jan 03Earnings Tell The Story For Avient Corporation (NYSE:AVNT)
Dec 18Is It Time To Consider Buying Avient Corporation (NYSE:AVNT)?
Nov 18Avient: Specialization Strategy Is Growing Margins And Driving The Bottom-Line Growth
Nov 13Avient's (NYSE:AVNT) Dividend Will Be Increased To $0.27
Nov 02Avient (NYSE:AVNT) Seems To Use Debt Quite Sensibly
Sep 26
Navigating Challenges, The Company Leverages Healthcare Innovations And Tactical Partnerships For Growth
Avient's strategy focuses on market share gain in varied sectors, especially healthcare, promising revenue growth with innovations like drug delivery devices.A Look At The Intrinsic Value Of Avient Corporation (NYSE:AVNT)
Aug 03Why Avient Corporation (NYSE:AVNT) Could Be Worth Watching
Jul 02With Avient Corporation (NYSE:AVNT) It Looks Like You'll Get What You Pay For
Jun 14Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Avient makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 25 | 3,260 | 82 | 701 | 0 |
| 30 Sep 25 | 3,246 | 113 | 707 | 0 |
| 30 Jun 25 | 3,255 | 119 | 713 | 0 |
| 31 Mar 25 | 3,238 | 100 | 719 | 0 |
| 31 Dec 24 | 3,240 | 170 | 713 | 0 |
| 30 Sep 24 | 3,213 | 149 | 689 | 0 |
| 30 Jun 24 | 3,151 | 116 | 666 | 0 |
| 31 Mar 24 | 3,126 | 104 | 659 | 0 |
| 31 Dec 23 | 3,143 | 76 | 672 | 0 |
| 30 Sep 23 | 3,214 | 31 | 715 | 0 |
| 30 Jun 23 | 3,284 | -1 | 709 | 0 |
| 31 Mar 23 | 3,350 | 39 | 691 | 0 |
| 31 Dec 22 | 3,397 | 83 | 653 | 0 |
| 30 Sep 22 | 3,414 | 108 | 631 | 0 |
| 30 Jun 22 | 3,408 | 169 | 639 | 0 |
| 31 Mar 22 | 3,045 | 137 | 631 | 0 |
| 31 Dec 21 | 3,316 | 152 | 661 | 0 |
| 30 Sep 21 | 3,506 | 218 | 655 | 0 |
| 30 Jun 21 | 3,612 | 186 | 665 | 0 |
| 31 Mar 21 | 3,693 | 178 | 617 | 0 |
| 31 Dec 20 | 2,215 | 71 | 506 | 0 |
| 30 Sep 20 | 2,904 | 64 | 474 | 0 |
| 30 Jun 20 | 2,685 | 86 | 418 | 0 |
| 31 Mar 20 | 2,824 | 86 | 442 | 0 |
| 31 Dec 19 | 2,863 | 76 | 486 | 0 |
| 30 Sep 19 | 2,881 | 68 | 483 | 0 |
| 30 Jun 19 | 2,905 | 77 | 474 | 0 |
| 31 Mar 19 | 2,730 | 62 | 452 | 0 |
| 31 Dec 18 | 2,881 | 88 | 456 | 0 |
| 30 Sep 18 | 3,005 | 124 | 451 | 0 |
| 30 Jun 18 | 3,094 | 132 | 450 | 0 |
| 31 Mar 18 | 3,335 | 173 | 457 | 0 |
| 31 Dec 17 | 2,590 | 111 | 419 | 0 |
| 30 Sep 17 | 3,124 | 173 | 416 | 0 |
| 30 Jun 17 | 3,052 | 176 | 403 | 0 |
| 31 Mar 17 | 2,996 | 176 | 389 | 0 |
| 31 Dec 16 | 2,939 | 166 | 390 | 0 |
| 30 Sep 16 | 3,020 | 134 | 418 | 0 |
| 30 Jun 16 | 3,115 | 136 | 422 | 0 |
| 31 Mar 16 | 3,243 | 153 | 425 | 0 |
| 31 Dec 15 | 2,929 | 148 | 394 | 0 |
| 30 Sep 15 | 3,471 | 127 | 455 | 0 |
| 30 Jun 15 | 3,588 | 115 | 466 | 0 |
Quality Earnings: AVNT has a large one-off loss of $141.4M impacting its last 12 months of financial results to 31st December, 2025.
Growing Profit Margin: AVNT's current net profit margins (2.5%) are lower than last year (5.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AVNT's earnings have declined by 8.7% per year over the past 5 years.
Accelerating Growth: AVNT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AVNT had negative earnings growth (-51.7%) over the past year, making it difficult to compare to the Chemicals industry average (0.1%).
Return on Equity
High ROE: AVNT's Return on Equity (3.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/30 03:53 |
| End of Day Share Price | 2026/04/30 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Avient Corporation is covered by 18 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ghansham Panjabi | Baird |
| Prashant Juvekar | Citigroup Inc |
| David Begleiter | Deutsche Bank |